| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥18.5B | ¥16.7B | +10.7% |
| Operating Income | ¥-1.3B | ¥-3.7B | +66.2% |
| Ordinary Income | ¥-1.0B | ¥-4.2B | +76.7% |
| Net Income | ¥-1.0B | ¥-4.0B | +74.5% |
| ROE | -6.1% | -24.8% | - |
FY2026 Q2 results show revenue of 18.5B yen (YoY +10.7%), operating loss of -1.3B yen (loss reduced by 66.2% from -3.7B yen YoY), ordinary loss of -1.0B yen (loss reduced by 76.7% from -4.2B yen YoY), and net loss of -1.0B yen (loss reduced by 74.5% from -4.0B yen YoY). The company continues to report losses but demonstrates clear improvement trajectory across all profit metrics. Revenue growth of 10.7% combined with gross margin maintenance at 34.6% reflects solid top-line recovery in the precision machining components business. Operating cash flow turned positive at 2.3B yen (YoY +111.6%), indicating improved cash generation despite continued accounting losses. The company maintains full-year guidance projecting revenue of 42.0B yen (YoY +24.9%) with anticipated return to operating profitability at 0.6B yen.
Revenue increased 10.7% YoY to 18.5B yen, driven by volume growth in the precision machining components business, the company's single operating segment. Gross profit reached 6.4B yen with gross margin of 34.6%, indicating stable production economics and favorable product mix or pricing. The primary profitability headwind remains elevated SG&A expenses of 7.7B yen (41.4% of revenue), which exceeded gross profit and generated operating loss of -1.3B yen (operating margin -6.8%). Despite the operating loss, the deficit narrowed significantly from -3.7B yen in the prior year period, representing a 2.4B yen improvement. This improvement stemmed from revenue growth of 1.8B yen outpacing the SG&A increase, suggesting operating leverage is beginning to emerge as the business scales. Non-operating items contributed net negative -0.3B yen, comprising foreign exchange gains of 0.4B yen offset by foreign exchange losses of 0.5B yen (net FX impact near neutral) and interest expense of 0.2B yen. The interest burden represents 22% of EBITDA, reflecting substantial debt servicing requirements. Ordinary loss of -1.0B yen improved 76.7% YoY, consistent with operating improvement. No material extraordinary items were recorded. Income tax expense was negligible at near-zero, consistent with loss-making status and likely utilization of tax loss carryforwards. Net loss of -1.0B yen improved 74.5% YoY, closely tracking ordinary income performance. Comprehensive income reached positive 0.5B yen, driven by foreign currency translation adjustments of 1.5B yen reflecting yen depreciation benefits on overseas assets and operations, plus remeasurements of defined benefit plans of 0.1B yen. The pattern is revenue up, losses down, representing a recovery trajectory where top-line growth is beginning to flow through to narrowing losses, though profitability breakeven remains dependent on further SG&A rationalization or revenue scaling.
[Profitability] ROE of -6.1% reflects continued losses, though substantially improved from deeper negative territory in the prior year. Operating margin of -6.8% remains negative but improved from -22.3% YoY, indicating progress toward breakeven as revenue growth outpaces fixed cost growth. Gross margin of 34.6% demonstrates acceptable product-level profitability, with the path to operating profitability dependent on SG&A leverage. Net profit margin of -5.5% improved from -24.0% YoY. EBITDA reached 0.03B yen (margin 0.2%), representing near-breakeven on a cash operating basis when excluding non-cash depreciation of 1.3B yen. [Cash Quality] Cash and deposits of 15.8B yen provide coverage of 1.40x against short-term borrowings of 11.3B yen, indicating adequate liquidity headroom. Cash conversion remains challenged with operating CF of 2.3B yen relative to net loss of -1.0B yen (CF/NI ratio of -2.26x), though the positive operating CF demonstrates underlying cash generation capability. Working capital management improved with accounts receivable declining 13.6% YoY to 10.8B yen and inventory declining 28.7% to 2.2B yen. [Investment Efficiency] Asset turnover of 0.30x reflects capital-intensive manufacturing operations. Inventory turnover improved to approximately 167 days, down from 233 days YoY as inventory compression initiatives took effect. Receivables turnover stands at approximately 213 days. ROIC remains negative consistent with loss-making operations. Capital expenditure of 0.07B yen represents only 5% of depreciation, indicating substantial investment restraint. [Financial Health] Equity ratio of 27.3% improved from 24.7% YoY but remains below the 48.6% industry median, reflecting elevated leverage. Current ratio of 128.4% and quick ratio of 120.6% indicate satisfactory short-term liquidity. Total interest-bearing debt of 26.4B yen represents debt-to-equity of 2.66x, substantially above conservative thresholds and reflecting accumulated losses and debt financing. Net debt-to-EBITDA of 619.9x is distorted by near-zero EBITDA. Interest coverage is negative given operating losses, though EBITDA of 0.03B yen nearly covers interest expense of 0.2B yen.
Operating cash flow of 2.3B yen represents a strong improvement from 1.1B yen in the prior year, driven by operating profit improvement and working capital optimization. The operating CF subtotal before working capital changes reached 2.4B yen, reflecting near-cash breakeven operations after adding back depreciation of 1.3B yen to the net loss. Working capital provided minimal net cash impact with inventory reduction contributing 1.0B yen inflow, receivables reduction contributing 1.7B yen inflow, offset by payables reduction consuming -0.7B yen. The substantial payables decrease from 1.0B yen to 0.3B yen suggests accelerated supplier payments, potentially reflecting improved liquidity management or negotiated payment terms. Income taxes paid were near zero at -0.03B yen, consistent with loss carryforward utilization. Investing cash flow of -0.16B yen was minimal, with capital expenditure of only 0.07B yen representing 5% of depreciation and indicating significant underinvestment in asset base renewal. Financing cash flow of -6.1B yen primarily reflected debt reduction, with short-term borrowings decreasing 5.0B yen from 16.3B yen to 11.3B yen and long-term debt payments of approximately 0.5B yen. Free cash flow of 2.1B yen (operating CF minus investing CF) was entirely applied to debt reduction. Cash and deposits decreased 3.3B yen from 19.1B yen to 15.8B yen as debt repayment exceeded operating cash generation. The cash flow profile demonstrates improving operational cash generation being prioritized for deleveraging over capital investment or shareholder returns.
Ordinary loss of -1.0B yen compared to operating loss of -1.3B yen indicates net non-operating contribution of approximately 0.3B yen. Non-operating income of 0.6B yen primarily comprised foreign exchange gains of 0.4B yen and other income of 0.1B yen, while non-operating expenses of 0.3B yen consisted of interest expense of 0.2B yen and foreign exchange losses of 0.5B yen. Net foreign exchange impact was marginally negative at approximately -0.1B yen. Non-operating items represent 3.2% of revenue in absolute terms (0.6B yen income plus 0.3B yen expense relative to 18.5B yen revenue), a relatively modest proportion. The composition is primarily financial and FX-related rather than equity method gains or other irregular items, providing reasonable transparency. Interest expense of 0.2B yen represents 22% of reported EBITDA, indicating substantial financial leverage impact. Operating cash flow of 2.3B yen substantially exceeds net loss in absolute terms, with the positive operating CF versus negative net income suggesting earnings quality is supported by non-cash charges (depreciation of 1.3B yen) and working capital improvements. Accruals assessment shows receivables and inventory reductions contributing to cash generation, indicating conservative working capital management. No material extraordinary items were recorded, enhancing comparability. Overall earnings quality is moderate, with core operating losses gradually improving and cash generation turning positive, though financial leverage and FX volatility introduce variability.
Progress against full-year guidance shows revenue of 18.5B yen represents 44.0% of the 42.0B yen full-year target, slightly below the standard 50% benchmark for Q2. Operating loss of -1.3B yen compares to full-year guidance of 0.6B yen operating profit, indicating H2 must generate approximately 1.9B yen operating profit to achieve the target, representing a significant sequential improvement requirement. Ordinary loss of -1.0B yen versus full-year ordinary profit target of 0.4B yen similarly requires approximately 1.4B yen H2 ordinary profit. The company maintained its full-year guidance without revision this quarter, suggesting management confidence in H2 recovery driven by continued revenue growth and operating leverage. Forecast assumptions reference business environment uncertainties and note that actual results may vary materially from projections. The implied H2 performance requires substantial margin expansion, likely dependent on revenue scaling to approximately 23.5B yen (assuming linear progression) and SG&A leverage or cost controls generating operating margin inflection to positive territory. Given H1 operating margin of -6.8%, achieving positive full-year operating margin of 1.4% (0.6B yen / 42.0B yen) implies H2 operating margin must reach approximately 9% to offset H1 losses, representing a significant operational inflection that would need to be driven by volume leverage, pricing, or cost restructuring.
Operating leverage risk remains elevated with SG&A expenses of 7.7B yen exceeding gross profit of 6.4B yen, requiring revenue growth of approximately 20% just to reach operating breakeven assuming stable gross margins and fixed cost base. Any revenue shortfall or gross margin compression would perpetuate losses. Financial leverage risk is substantial with debt-to-equity of 2.66x and interest-bearing debt of 26.4B yen against equity of 16.8B yen. Interest expense of 0.2B yen per half-year (0.4B yen annualized) represents substantial fixed financial obligations, and net debt-to-EBITDA of 619.9x reflects minimal debt servicing capacity from current operations. Short-term debt of 11.3B yen represents 43% of total liabilities, creating refinancing risk if operating performance fails to improve or credit conditions tighten. Capital investment deficiency risk emerges from capital expenditure of only 0.07B yen representing 5% of depreciation of 1.3B yen, indicating the asset base is not being renewed at depreciation rates. Sustained underinvestment (CapEx/Depreciation of 0.05x) may impair production efficiency, quality, or capacity to support projected revenue growth of 24.9%, potentially constraining the business recovery trajectory or necessitating lumpy future capital outlays.
[Industry Position] (Reference - Proprietary Analysis)
The company's performance relative to the manufacturing industry median shows profitability substantially below peers. Operating margin of -6.8% compares unfavorably to industry median of 8.8% (IQR 3.0% to 11.0%), placing the company in the bottom quartile and reflecting the loss-making status. Net profit margin of -5.5% similarly trails the industry median of 5.4% (IQR 1.1% to 8.2%). ROE of -6.1% compares to industry median of 4.4% (IQR 1.4% to 8.7%), and ROA is similarly negative versus industry median of 1.9%. Revenue growth of 10.7% YoY approximates the industry median of 11.7% (IQR -5.4% to 28.3%), indicating competitive top-line momentum despite profitability challenges. The equity ratio of 27.3% falls below the industry median of 48.6% (IQR 26.7% to 65.2%), placing the company at the lower end of the range and reflecting elevated leverage. Financial leverage of 3.66x exceeds the industry median of 1.72x (IQR 1.51x to 3.63x), confirming above-peer leverage utilization. Current ratio of 128.4% is below the industry median of 2.74x, though the limited sample size (n=3) reduces comparability. Asset turnover of 0.30x falls below the industry median of 0.36x, suggesting lower capital efficiency. Operating working capital turnover of approximately 169 days aligns with the industry median of 169.52 days, indicating comparable working capital management. Overall, the company demonstrates competitive revenue growth and working capital efficiency but lags significantly on profitability, capital efficiency, and financial health metrics relative to manufacturing industry peers.
(Industry: Manufacturing (n=7), Comparison: FY2025-Q2 benchmarks, Source: Proprietary analysis)
Loss reduction trajectory with all profit metrics improving substantially YoY (operating loss reduced 66.2%, ordinary loss reduced 76.7%, net loss reduced 74.5%) indicates clear recovery momentum. The path to profitability is visible with gross margin of 34.6% providing positive unit economics and operating leverage emerging as revenue growth of 10.7% outpaces SG&A growth. EBITDA reached near-breakeven at 0.03B yen (margin 0.2%), suggesting the company is approaching cash operating profitability. Full-year guidance projecting return to operating profit of 0.6B yen implies management expects continued improvement, though achievement requires significant H2 margin expansion. Operating cash flow inflection with 2.3B yen positive operating CF (YoY +111.6%) despite net losses demonstrates underlying cash generation capability, driven by working capital optimization including inventory reduction of 28.7% YoY and receivables reduction of 13.6% YoY. FCF of 2.1B yen was entirely allocated to debt reduction, with short-term borrowings declining 5.0B yen to 11.3B yen, reflecting prioritization of deleveraging. However, structural challenges remain with elevated financial leverage of D/E 2.66x, equity ratio of 27.3% below industry median of 48.6%, and interest burden consuming 22% of EBITDA. Investment underinvestment is evident with CapEx of 0.07B yen representing only 5% of depreciation, potentially constraining medium-term competitive positioning and capacity to support the projected 24.9% revenue growth. The company operates in a single segment (precision machining components), creating concentration risk without business diversification to offset cyclical or customer-specific exposures.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.